Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure

Aim. To investigate clinical efficacy of nebivolol and metoprolol in the complex treatment of patients with coronary heart disease (CHD) and II-III functional class chronic heart failure (CHF). Material and methods. The study involved 110 patients with CHD and CHF, functional class II-III, by NYHA c...

Full description

Bibliographic Details
Main Authors:	A. G. Evdokimova, A. E. Radzevich, O. I. Tereshchenko, E. V. Kovalenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2005-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary heart disease chronic heart failure hemodynamics remodeling nebivolol metoprolol
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/931

Similar Items

NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. L. Dzhanaeva, et al.
Published: (2012-02-01)

Efficacy of trimetazidine combining with metoprolol on plasma BNP in coronary heart disease patients with heart failure
by: Ping Li, et al.
Published: (2016-01-01)

EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
by: N. A. Koryagina, et al.
Published: (2014-12-01)

THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure
by: Yasser Gaber Metwally, et al.
Published: (2020-09-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Metoprolol and atenolol in mild-to-moderate chronic heart failure: The comparison of survival benefit
by: Ćelić Vera, et al.
Published: (2005-01-01)

CHANGING SYTOLIC AND DIASTOLIC LV FUNCTION IN CHRONIC HEART FAILURE UNDER THE INFLUENCE OF METOPROLOL
by: T. S. Jahangirov, et al.
Published: (2001-10-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study
by: Cheng X, et al.
Published: (2020-08-01)

Charakterisierung der Prostaglandin E\(_2\)-Transporte im proximalen Tubulus der Niere im ischämischen akuten Nierenversagen der Ratte unter Einfluss der Gabe von Nebivolol und Metoprolol Tartrat
by: Heck, Sigrun
Published: (2020)

Clinico-immunological disorders in patients with ischemic heart disease and metabolic syndrome: correction with nebivolol
by: A T Teplyakov, et al.
Published: (2008-12-01)

Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders
by: Liu X, et al.
Published: (2017-01-01)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

Effects of metoprolol on hemodynamics and entropy during endotracheal intubation
by: Qiang ZHOU, et al.
Published: (2010-08-01)

Features of The Heart Remodeling in Patients with Chronic Obstructive Pulmonary Diseases, Combined with Coronary Heart Diseases
by: A.Yu. Ryabova, et al.
Published: (2009-09-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

NEBIVOLOL SAFETY AS CARDIOSELECTIVE Β-BLOCKER IN COMPLEX THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY CHRONIC OBSTRUCTIVE BRONCHITIS
by: Zh. G. Simonova, et al.
Published: (2003-10-01)

Heart Rate Variability Predicts Therapeutic Response to Metoprolol in Children With Postural Tachycardia Syndrome
by: Yuanyuan Wang, et al.
Published: (2019-11-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

Evaluation of efficacy of metoprolol in patients having heart failure with preserved ejection fraction: A randomized, double-blind, placebo-controlled pilot trial
by: Niti Mittal, et al.
Published: (2017-01-01)

TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
by: V. E. Oleinikov, et al.
Published: (2015-12-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

Heart rate variability during orthostatic test, and central hemodynamic parameters in coronary heart disease patients with arterial hypertension
by: A. D. Ibatov
Published: (2004-02-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01)

Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
by: Yu. N. Belenkov, et al.
Published: (2011-02-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Effects of Metoprolol on Experimental Spinal Cord Ischemia-Reperfusion Injury in Rats
by: Serap Ozer Yaman, et al.
Published: (2021-01-01)

Features of structural and functional changes in the cardiovascular system and their correction in patients with chronic heart failure in combination with cardiopulmonary pathology
by: V. V Evdokimov, et al.
Published: (2018-03-01)

Effect of Nebivolol on MIBG Parameters and Exercise in Heart Failure with Normal Ejection Fraction
by: Leandro Rocha Messias, et al.
Published: (2016-01-01)

Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study
by: T V Martyniuk, et al.
Published: (2012-12-01)

INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
by: V. G. Tregubov, et al.
Published: (2016-01-01)

INCIDENCE OF HEART FAILURE IN DIABETICS WITH CORONARY HEART DISEASE
by: Stojan Radić, et al.
Published: (2003-01-01)

Comparison of the safety and efficacy of ivabradine and nebivolol mono- and combination therapies in the treatment of stable angina pectoris patients with left ventricular dysfunction
by: Rasim Kutlu, et al.
Published: (2013-06-01)

Cannot write session to /tmp/vufind_sessions/sess_vrfh6c29sjc6hi07tb3cpgdtfd